UBS Group’s Adtran ADTN Stock Holding History

UBS Group’s Portfolio ADTN Stock Details ADTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-17,980	Closed	-$193K	–	7685
2018 Q4	$193K	Buy	+17,980	New	+$245K	﹤0.01%	4978

Other funds holding ADTN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group's ADTN Position: Q2 2026 in Review

UBS Group increased its Adtran (ADTN) stake by 1,080% in Q2 2026, buying an estimated $42M and bringing the position to 2,940,724 shares worth $40.9M. The position accounts for 0.01% of the portfolio, ranked #1954.

UBS Group first reported a position in ADTN in Q4 2014 and has held it in 45 quarters since. 249 funds tracked by Wall St. Rank hold ADTN as of Q2 2026.

UBS Group held 2,940,724 shares of Adtran worth $40.9M as of Q2 2026.
UBS Group bought 2,691,567 Adtran shares in Q2 2026, an estimated $42M.
Adtran made up 0.01% of UBS Group's portfolio in Q2 2026, its #1954 holding.
UBS Group first reported a position in Adtran in Q4 2014 and has held it in 45 quarters since.
249 funds tracked by Wall St. Rank held Adtran as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.